HIV Treatment: First-Line, Alternatives, and Clinical Pearls - Guidelines by HHS

HHS HIV Guidelines Explained: First-Line & Practical Antiretroviral Therapy In this episode, we dive deep into the U.S. Department of Health and Human Services (HHS) HIV treatment guidelines to help you confidently navigate antiretroviral therapy (ART) selection and management. Whether you’re a pharmacist, physician, nurse, or healthcare student, you’ll learn how to make informed, patient-centered decisions in real-world HIV care. What You’ll Learn: Recommended first-line ART regimens and why they’re preferred. When to choose alternative regimens and common clinical scenarios for switching. Practical strategies for starting and optimizing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide). Long-acting injectable options and when to consider them—even in patients with detectable viral loads. Real-world approaches to improve adherence and patient outcomes. Why This Matters: This is more than a guideline review—it’s a practical toolkit for clinicians working in HIV care. We’ll connect the science to the clinic so you can better support your patients’ quality of life and long-term health. 📚 Reference: U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. 💬 Have a question or case scenario? Drop it in the comments so we can discuss it in future episodes. 🔔 Like, share, and subscribe to join our growing community of healthcare professionals dedicated to excellence in HIV care.